Apply Give

Other ways to search: Events Calendar | UTHSC

MDMA approval for post-traumatic stress disorder could come in 2024

Written by Communications and Marketing

|

The Food and Drug Administration soon may approve the recreational psychedelic drug MDMA — alongside supportive therapy — to treat post-traumatic stress disorder after two late-stage studies found it effective. MDMA facilitates empathy and openness and decreases defensiveness, but it also induces neuroplasticity — the ability of neurons to rewire and strengthen connections, said Ronald Cowan, professor and chair of the department of psychiatry at the University of Tennessee Health Science Center in Memphis.

Top Publishers